You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 5, May 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Statistics and Research Methods
 •Diagnosis
 •Pediatric Ophthalmology
 •Retinal/ Chorioretinal Disorders
 •Pediatrics
 •Neonatology and Infant Care
 •Alert me on articles by topic

Flawed Study Design in Report on Interexpert Agreement of Plus Disease Diagnosis in Retinopathy of Prematurity—Reply

Michael F. Chiang, MD; Lei Jiang, BA; Rony Gelman, MD; Yunling E. Du, PhD; John T. Flynn, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We appreciate the opportunity to respond to the thoughtful comments by Drs Good, Palmer, and Hardy. With regard to study design issues: (1) We agree that a contact retinal camera can alter the appearance of retinal vessels but note that many of these same changes may occur during indirect ophthalmoscopy with scleral depression. (2) It is true that our study images were presented to graders without peripheral views or demographic data. However, the standard photographic definition of plus disease also displays only the posterior retina.1 Future research to determine whether this additional information would influence diagnostic reliability may be warranted. (3) We agree that our study did not directly measure whether multiple experts performing serial ophthalmoscopy on the same infants would diagnose plus disease consistently. The strengths and limitations of . . . [Full Text of this Article]


AUTHOR INFORMATION

RELATED ARTICLES

Interexpert Agreement of Plus Disease Diagnosis in Retinopathy of Prematurity
Michael F. Chiang, Lei Jiang, Rony Gelman, Yunling E. Du, and John T. Flynn
Arch Ophthalmol. 2007;125(7):875-880.
ABSTRACT | FULL TEXT  

It's Plus Disease, Isn't It?
Dale L. Phelps
Arch Ophthalmol. 2007;125(7):963-964.
EXTRACT | FULL TEXT  

Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial
Early Treatment for Retinopathy of Prematurity Cooperative Group
Arch Ophthalmol. 2003;121(12):1684-1694.
ABSTRACT | FULL TEXT  

Evidence-Based Screening Criteria for Retinopathy of Prematurity: Natural History Data From the CRYO-ROP and LIGHT-ROP Studies
James D. Reynolds, Velma Dobson, Graham E. Quinn, Alistair R. Fielder, Earl A. Palmer, Richard A. Saunders, Robert J. Hardy, Dale L. Phelps, John D. Baker, Michael T. Trese, David Schaffer, Betty Tung, and for the CRYO-ROP and LIGHT-ROP Cooperative Groups
Arch Ophthalmol. 2002;120(11):1470-1476.
ABSTRACT | FULL TEXT  

RELATED LETTER

Flawed Study Design in Report on Interexpert Agreement of Plus Disease Diagnosis in Retinopathy of Prematurity
William V. Good, Earl A. Palmer, and Robert J. Hardy
Arch Ophthalmol. 2008;126(5):740.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.